Essex Bio-Technology Limited (1061.HK)
HKD 2.76
(0.37%)
HKD 2.76
(0.37%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 62.82 Million HKD | -24.91% |
| 2022 | 83.65 Million HKD | -14.26% |
| 2021 | 97.57 Million HKD | -33.64% |
| 2020 | 147.03 Million HKD | 28.84% |
| 2019 | 114.12 Million HKD | 61.31% |
| 2018 | 70.74 Million HKD | -31.22% |
| 2017 | 102.86 Million HKD | -3.15% |
| 2016 | 106.21 Million HKD | 174.61% |
| 2015 | 38.67 Million HKD | 9.82% |
| 2014 | 35.22 Million HKD | 446.14% |
| 2013 | 6.44 Million HKD | 49.67% |
| 2012 | 4.3 Million HKD | 1.09% |
| 2011 | 4.26 Million HKD | 16.39% |
| 2010 | 3.66 Million HKD | 65.33% |
| 2009 | 2.21 Million HKD | -96.01% |
| 2008 | 55.44 Million HKD | 181.61% |
| 2007 | 19.68 Million HKD | 244.09% |
| 2006 | 5.72 Million HKD | 179.45% |
| 2005 | 2.04 Million HKD | 338.41% |
| 2004 | 467.04 Thousand HKD | 8.81% |
| 2003 | 429.23 Thousand HKD | -73.31% |
| 2002 | 1.6 Million HKD | 173.04% |
| 2001 | 588.96 Thousand HKD | -21.95% |
| 2000 | 754.6 Thousand HKD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 72.28 Million HKD | 0.0% |
| 2023 FY | 62.82 Million HKD | -24.91% |
| 2023 Q2 | 68.02 Million HKD | 0.0% |
| 2023 Q4 | 62.82 Million HKD | 0.0% |
| 2022 Q2 | 84.27 Million HKD | 0.0% |
| 2022 FY | 83.65 Million HKD | -14.26% |
| 2022 Q4 | 83.65 Million HKD | 0.0% |
| 2021 Q2 | 126.06 Million HKD | 0.0% |
| 2021 Q4 | 97.57 Million HKD | 0.0% |
| 2021 FY | 97.57 Million HKD | -33.64% |
| 2020 Q2 | 120.31 Million HKD | 0.0% |
| 2020 FY | 147.03 Million HKD | 28.84% |
| 2020 Q4 | 147.03 Million HKD | 0.0% |
| 2019 Q4 | 114.12 Million HKD | 0.0% |
| 2019 Q2 | 61.07 Million HKD | 0.0% |
| 2019 FY | 114.12 Million HKD | 61.31% |
| 2018 Q2 | 115.95 Million HKD | 0.0% |
| 2018 Q4 | 70.74 Million HKD | 0.0% |
| 2018 FY | 70.74 Million HKD | -31.22% |
| 2017 FY | 102.86 Million HKD | -3.15% |
| 2017 Q2 | 94.2 Million HKD | 0.0% |
| 2017 Q4 | 102.86 Million HKD | 0.0% |
| 2016 Q4 | 106.21 Million HKD | 0.0% |
| 2016 Q2 | 46.34 Million HKD | 0.0% |
| 2016 FY | 106.21 Million HKD | 174.61% |
| 2015 Q4 | 38.67 Million HKD | 0.0% |
| 2015 Q2 | 46.5 Million HKD | 0.0% |
| 2015 FY | 38.67 Million HKD | 9.82% |
| 2014 Q2 | 18.96 Million HKD | 0.0% |
| 2014 Q4 | 35.22 Million HKD | 0.0% |
| 2014 FY | 35.22 Million HKD | 446.14% |
| 2013 Q4 | 6.44 Million HKD | 0.0% |
| 2013 FY | 6.44 Million HKD | 49.67% |
| 2013 Q2 | 3.7 Million HKD | 0.0% |
| 2012 Q4 | 4.3 Million HKD | 0.0% |
| 2012 FY | 4.3 Million HKD | 1.09% |
| 2012 Q2 | 3.21 Million HKD | 0.0% |
| 2011 FY | 4.26 Million HKD | 16.39% |
| 2011 Q4 | 4.26 Million HKD | 0.0% |
| 2011 Q2 | 3.08 Million HKD | 0.0% |
| 2010 Q2 | 3.06 Million HKD | 0.0% |
| 2010 FY | 3.66 Million HKD | 65.33% |
| 2009 FY | 2.21 Million HKD | -96.01% |
| 2008 FY | 55.44 Million HKD | 181.61% |
| 2007 FY | 19.68 Million HKD | 244.09% |
| 2006 FY | 5.72 Million HKD | 179.45% |
| 2005 FY | 2.04 Million HKD | 338.41% |
| 2004 FY | 467.04 Thousand HKD | 8.81% |
| 2003 FY | 429.23 Thousand HKD | -73.31% |
| 2002 FY | 1.6 Million HKD | 173.04% |
| 2001 FY | 588.96 Thousand HKD | -21.95% |
| 2000 FY | 754.6 Thousand HKD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 12.19 Million HKD | -415.06% |
| Grand Pharmaceutical Group Limited | 1.38 Billion HKD | 95.476% |
| Extrawell Pharmaceutical Holdings Limited | 7.26 Million HKD | -764.72% |
| Wai Yuen Tong Medicine Holdings Limited | 308.09 Million HKD | 79.61% |
| Qianhai Health Holdings Limited | 431.78 Million HKD | 85.451% |
| Lee's Pharmaceutical Holdings Limited | 298.1 Million HKD | 78.926% |
| Tongfang Kontafarma Holdings Limited | 98.26 Million HKD | 36.07% |
| PuraPharm Corporation Limited | 175.59 Million HKD | 64.224% |
| SSY Group Limited | 1.08 Billion HKD | 94.217% |
| JBM (Healthcare) Limited | 91.58 Million HKD | 31.406% |
| Jacobson Pharma Corporation Limited | 317.85 Million HKD | 80.236% |
| China Resources Pharmaceutical Group Limited | 35.09 Billion HKD | 99.821% |